1. Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences 
Zobair M. Younossi, Aybike Birerdinc, Linda Henry 
Journal of Hepatology 
Volume 65, Issue 1, Pages S109-S119 (October 2016)
DOI: /j.jhep
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
How to capture the comprehensive benefits approach for measuring the burden of HCV to patients and to society. HCV, hepatitis C virus; EHM, extra-hepatic manifestations; HQRL, health-related quality of life; WP, window phase; ICER, incremental cost-effectiveness ratio; PRO, patient related outcomes.
Journal of Hepatology  , S109-S119DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
HCV and progression of liver disease. HCV, hepatitis C virus; SVR, sustained virological response; HCC, hepatocellular carcinoma; USA, United States of America.
Journal of Hepatology  , S109-S119DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions